Bech JN - Search Results

1

Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial.

Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Larsen T, et al. Among authors: bech jn. Am J Hypertens. 2012 Nov;25(11):1215-22. doi: 10.1038/ajh.2012.111. Epub 2012 Aug 2. Am J Hypertens. 2012. PMID: 22854639 Clinical Trial.

2

Epoprostenol increases plasma level of atrial natriuretic peptide in humans.

Nielsen CB, Bech JN, Pedersen EB. Nielsen CB, et al. Among authors: bech jn. Clin Sci (Lond). 1996 Feb;90(2):87-9. doi: 10.1042/cs0900087. Clin Sci (Lond). 1996. PMID: 8829885 Clinical Trial.

3

Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.

Bech JN, Nielsen CB, Pedersen EB. Bech JN, et al. Am J Physiol. 1996 May;270(5 Pt 2):F845-51. doi: 10.1152/ajprenal.1996.270.5.F845. Am J Physiol. 1996. PMID: 8928847 Clinical Trial.

4

Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.

Nielsen CB, Bech JN, Pedersen EB. Nielsen CB, et al. Among authors: bech jn. Br J Clin Pharmacol. 1997 Nov;44(5):471-6. doi: 10.1046/j.1365-2125.1997.t01-1-00608.x. Br J Clin Pharmacol. 1997. PMID: 9384464 Free PMC article. Clinical Trial.

5

A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two years.

Pedersen EB, Bech JN, Nielsen CB, Kornerup HJ, Hansen HE, Spencer ES, Sølling J, Jensen KT. Pedersen EB, et al. Among authors: bech jn. Scand J Clin Lab Invest. 1997 Dec;57(8):673-81. doi: 10.3109/00365519709105228. Scand J Clin Lab Invest. 1997. PMID: 9458489 Clinical Trial.

6

Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.

Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Bech JN, et al. Am J Physiol. 1998 May;274(5):F914-23. doi: 10.1152/ajprenal.1998.274.5.F914. Am J Physiol. 1998. PMID: 9612329 Clinical Trial.

7

The systemic and renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans.

Bech JN, Svendsen KB, Nielsen CB, Pedersen EB. Bech JN, et al. Nephrol Dial Transplant. 1999 Mar;14(3):641-7. doi: 10.1093/ndt/14.3.641. Nephrol Dial Transplant. 1999. PMID: 10193813 Clinical Trial.

8

L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men.

Fisker S, Nielsen S, Ebdrup L, Bech JN, Christiansen JS, Pedersen EB, Jørgensen JO. Fisker S, et al. Among authors: bech jn. Growth Horm IGF Res. 1999 Feb;9(1):69-73. doi: 10.1054/ghir.1999.0089. Growth Horm IGF Res. 1999. PMID: 10207510

9

The role of nitric oxide in L-arginine-stimulated growth hormone release.

Fisker S, Nielsen S, Ebdrup L, Bech JN, Christiansen JS, Pedersen EB, Jørgensen JO. Fisker S, et al. Among authors: bech jn. J Endocrinol Invest. 1999;22(5 Suppl):89-93. J Endocrinol Invest. 1999. PMID: 10442577 Review.

10

A randomized, double-blind, parallel study on the safety and antihypertensive efficacy of losartan compared to captopril in patients with mild to moderate hypertension and impaired renal function.

Schulz E, Bech JN, Pedersen EB, Müller GA. Schulz E, et al. Among authors: bech jn. Nephrol Dial Transplant. 1999;14 Suppl 4:27-8. doi: 10.1093/ndt/14.suppl_4.27. Nephrol Dial Transplant. 1999. PMID: 10463203 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page